Clinical significance of the laboratory determinations in preeclamptic patients;Significado clínico de los resultados de laboratorio en las pacientes preeclámpticas

Ginecologia y Obstetricia de Mexico

Volumn 72, Issue 2, 2004, Pages 57-62

  Peralta Pedrero, María Luisa ^a,d   Basavilvazo Rodríguez, Ma Antonia ^a   Cruz Avelar, Agles ^b   Sánchez Ambríz, Silvia ^a   Guzmán Ibarra, María De Los Ángeles ^a   Martínez García, María Del Carmen ^a,c  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c HOSPITAL DE PEDIATRÍA   (Mexico)

^d NONE   (Mexico)

Author keywords

Diagnosis; Diagnostic tests; Laboratory tests; Pre eclampsia

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; LACTATE DEHYDROGENASE; PROTHROMBIN; URIC ACID;

ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HEMATOCRIT; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; PREECLAMPSIA; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT; THROMBOPLASTIN TIME; ADULT; BLOOD; BLOOD CELL COUNT; BLOOD CLOTTING TEST; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; PREGNANCY;

ADULT; BLOOD CELL COUNT; BLOOD COAGULATION TESTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY FUNCTION TESTS; LIVER FUNCTION TESTS; PRE-ECLAMPSIA; PREGNANCY; SENSITIVITY AND SPECIFICITY;

EID: 3142626722     PISSN: 03009041     EISSN: 03009041     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183: S1-S22.
2. Australasian Society for the Study of Hypertension in Pregnancy. Management of hypertension in pregnancy: Executive summary. Med J Aust 1993; 158:700-2.
3. Barron W, Heckerling P, Hibbard JU, Fisher S. Reducing unnecessary coagulation testing in hypertensive disorders of pregnancy. Obstet Gynecol 1999; 94:364-70.
4. Sibai B. Pitfalls in diagnosis and management of preeclampsia. Am J Obstet Gynecol 1988; 159: 1-5.
5. Socol ML, Weiner CP, Louis G, Rehnberg, Rossi E. Platelet activation in preeclampsia. Am J Obstet Gynecol 1985; 151:494-97.
6. Martínez AE, Angulo VA, Vargas GA, González OM. Alteraciones de coagulación en la paciente eclámptica. Ginecol Obstet Mex 1990; 58:211-15.
7. Costero C. Hepatopatías del embarazo. Ginecol Obstet Mex 1993; 61:66-71.
8. Rolfes DB, Ishak KG. Liver disease in toxemia of pregnancy. Am J Gastroenterol 1986; 81: 1138-44.
9. Girling JC, Smith JH. Liver function test in pre-eclampsia: importance of comparison with a reference range derived for normal pregnancy. Br J Obstet Gynaecol 1997; 104: 246-50.
10. a ed. México: Masson, 1996.
11. Dekker GA, Sibai BM. Primary, secondary and tertiary prevention of pre-eclampsia. Lancet 2001; 20: 209-12.
12. ACOG Technical Bulletin. Hypertension in pregnancy. No. 219-January 1996. Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1996; 53:175-83.
13. Zamorsky M, Green L. NHBPEP Report on High Blood Pressure in Pregnancy: a summary for Family Physicians. Am Fam Physician 2001; 64:263-70.
14. Rodríguez GD, Velarde IR. Preeclampsia severa y síndrome de Hellp. Ginecol Obstet Mex 1995; 63:325-29.
15. Chavarría ME, González G, Lara GA, et al. Concentración plasmática de indicadores bioquímicos en la preeclampsia-eclampsia y su asociación con la gravedad de la patología. Ginecol Obstet Mex 2000; 68:385-93.
16. Kramer RL, Izquierdo LA, Glison GJ, Curet LB, Qualls CR. "Preeclamptic Labs" for evaluating hypertension in pregnancy. J Reprod Med 1997; 42:223-28.
17. Leduc L, Wheeler J, Kirshon B, Mitchell P, Cotton D. Coagulation profile in severe preeclampsia. Obstet Gynecol 1992; 79:14-18.
18. Martin JN, Rinehart BK, May WL, Magna EF, Terrone DA, Blake P. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol 1999; 180:1373-84.
19. Freund G, Arvan D. Clinical biochemistry of preeclampsia and related liver diseases of pregnancy a review. Clin Chim Acta 1990; 191:123-52.
20. Martin NJ, May WL, Magann EF, Terrone DA, Rinehart BK, Blake PG. Early risk assessment of severe preeclampsia: Admission battery of symptoms and laboratory test to predict likelihood of subsequent significant maternal morbidity. Am J Obstet Gynecol 1999; 180:1407-14.
21. Sainio S, Kekomaki R, Riikonen S, Teramo K. Maternal thrombocytopenia at term: a population-based study. Acta Obstet Gynecol Scand 2000; 79: 744-49.
22. Hill LM. Metabolism of uric acid in normal and toxemic pregnancy. Mayo Clin Proc 1978; 53:743-51.
23. Lind T, Godfrey A, Outun H. Changes in serum uric acid concentrations during normal pregnancy. Br J Obstet Gynaecol 1984; 91:128-32.
24. Méndez-Velarde FA, Salceda-Pérez MA, Castillo-Ortega MM, et al. Valor pronóstico del ácido úrico en pacientes preeclámpticas. Bol Clin Hosp Edo Son 2000; 17:6-9
25. Hsu Ch, Chung YK, LeeI S, Cou Kent, Copel JA. Maternal serum uric acid levels in preeclamptic women with multiple gestations. Am J Perinat 1997; 14:613-17.